• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.63% Nasdaq Up0.17%

    Oncothyreon Inc (ONTY)

    -NasdaqGS
    1.90 Up 0.10(5.28%) 2:56PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue -   -   145  
    Cost of Revenue -   -   -  
    Gross Profit -   -   145  
    Operating Expenses
    Research Development33,221  22,001  17,915  
    Selling General and Administrative8,002  6,498  6,929  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (41,223) (28,499) (24,699)
    Income from Continuing Operations
    Total Other Income/Expenses Net2,464  25,393  (17,326)
    Earnings Before Interest And Taxes(38,759)(3,106)(42,025)
    Interest Expense -  309  631  
    Income Before Tax(38,759)(3,415)(42,656)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(38,759)(3,415)(42,656)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (38,759) (3,415) (42,656)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (38,759) (3,415) (42,656)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.